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1. Introduction 
The microsomal fraction of liver homogenate 
catalyzes hydroxylation of steroids in a number of 
different positions [ 11. The positions hydroxylated 
often vary with the steroid and a given steroid is 
frequently hydroxylated only in a limited number of 
positions. Different steroids may be hydroxylated in 
the same position or positions. The question of the 
multiplicity of the enzyme system catalyzing hydrox- 
ylation of steroids has not been resolved nor are the 
factors governing the positional specificity of the 
enzyme system(s) known. In a recent report from 
this laboratory some aspects of the microsomal 
hydroxyiation of cholesterol, pregnenolone* and 
dehydroepiandrosterone were studied with the aim of 
gathering information relevant to these questions [2]. 
Part of the investigation concerned the properties of 
the system(s) catalyzing 7a-hydroxylation of these 
substrates. Marked differences were observed be- 
tween 7ar-hydroxylation of cholesterol and 7~ 
hydroxylation of pregnenolone and dehydroepi- 
androsterone. The pattern of hydroxylations of 
pregnenolone and dehydroepiandrosterone also differ- 
ed. Whereas the 7a-hydroxylated derivative was a 
major product of dehydroepiandrosterone, 7at-hydroxy- 
prenenolone was a minor product of prenenolone. 
Instead, an unidentified compound or compounds 
with thin-layer chromatographic properties similar to 
those of 7/3-hydroxypregnenolone was the major pro- 
duct. The present communication reports the identi- 
fication of the unknown as a mixture of about 85% 
2&-hydroxypregnenolone and about 15% of 2& 
hydroxypregnenolone. 
* Trivial names: pregnenolone, 3p-hydroxy-5-pregnen-20-one; 
dehydroepiandrosterone, 3p-hydroxy-5-androsten-17-one. 
North-Holland Publishing Company - Amsterdam 
2. Experimental 
2.1. Materials 
[4-14C]Pregnenolone (Radiochemical Centre, 
Amersham, England) was purified by chromatography 
on a column of hydroxyalkoxypropyl-Sephadex with 
methanol-water-l ,2-dichloroethane (7:3: 1, v/v/v) 
as solvent [3]. The purified material was diluted with 
unlabelled pregnenolone and crystallized from an 
acetone-water mixture to yield material with a spe- 
cific radioactivity of 3 pCi/mg. 
2.2. Methods 
Male rats of the Sprague-Dawley strain weighing 
150-200 g were used. Liver homogenates (20%, w/v) 
were prepared in 0.25 M sucrose containing 0.001 M 
EDTA and the microsomal fraction was isolated as 
described previously [2]. The microsomal fraction 
was suspended in 0.1 M potassium phosphate buffer, 
pH 7.0, containing 0.028 M nicotinamide in a volume 
corresponding to the original volume of the 20,000 g 
supernatant fluid. Each incubation mixture consisted 
of 1 ml of microsomal fraction, 3 pmoles of NADPH 
and 2 ml of buffer. [4-14C]Pregnenolone, 100 ,ug in 
50 ,ul of acetone, was added and incubation was 
carried out for 20 min at 37”. The incubation was 
terminated by the addition of 20 vol of chloroform- 
methanol (2: 1, v/v). The precipitate was filtered off 
and 0.2 vol of a 0.9% (w/v) sodium chloride solution 
were added. The residue of the chloroform phase 
was subjected to thin-layer chromatography with 
Kieselgel G (Merck, Darmstadt, Germany) as adsor- 
bent and 2,2,4+imethylpentane-isoamyl acetate- 
acetone (2:2: 1, v/v/v) as solvent. The chromatoplate 
was run three times in the same solvent with drying 
of the plate between the runs. 
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Fig. 1. Thin-layer chromatogram of extract of incubation of 
[4-‘4C]pregnenolone with microsomal fraction of rat liver 
homogenate fortified with NADPH. Reference compounds 
were: 1) 7a-hydroxypregnenolone; 2) 7@hydroxypregnenolone; 
3) 16a-hydroxypregnenolone; 4) 7-ketopregnenolone. 
Radio-gas chromatography was performed with a 
Barber-Colman 5000 instrument equipped with a 1% 
QF-1 or 1% SE-30 column. Combined gas chromato- 
graphy-mass spectrometry was performed with an 
LKB 9000 instrument equipped with a 1.5% SE-30 
column. 
Catalytic hydrogenation of the A5 double bond 
was performed in ethanol with 10% palladium on 
charcoal as catalyst [4]. Acetonides were prepared as 
described by McCloskey and McClelland [5]. 
3. Results 
A series of ten incubations of [4-14C]pregnenolone 
was carried out with the microsomal fraction of rat 
liver homogenate fortified with NADPH. The extracts 
of the incubations were subjected to thin-layer 
chromatography (fig. 1). After autoradiography the 
labelled zones having about the mobility of reference 
7/3-hydroxypregnenolone were collected. The material 
was pooled and chromatographed on a column of 
hydroxyalkoxypropyl-Sephadex with chlorofomr- 
hexane (1: 1, v/v) as solvent (fig. 2). Two peaks con- 
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Fig. 2. Chromatogram of unknown on hydroxyalkoxypropyl- 
Sephadex. Column, 10 g; solvent, chloroform-hexane, 1: 1 
(v/v). 
taming radioactivity (A, 3343 ml of effluent, and 
B, 51-72 ml of effluent) were seen. Aliquots of both 
were converted to trimethylsilyl ethers and subjected 
individually to radio-gas chromatography and com- 
bined gas chromatography-mass spectrometry. Upon 
radio-gas chromatography each compound gave a single 
peak of mass and radioactivity. Upon combined gas 
chromatography-mass spectrometry again single peaks 
were observed. The tR (retention time relative to 
cholestane) of compound A on a column of 1.5% 
SE-30 was 0.95 and that of compound B 1.3 1. The 
mass spectra of compounds A and B were practically 
identical (fig. 3 a and b). The base peak was at m/e 
386 (M-90 (trimethylsilanol)). Peaks were seen also 
at m/e 461 (M-15). m/e 371 (M-(90+15)) and m/e 
(N-2 X 90). The mass spectra were similar to those of 
the trimethylsilyl ethers of 7~ and ‘I/3-hydroxy- 
pregnenolone [6] and indicated that compounds A 
and B were dihydroxypregnenolones. Compounds A 
and B were hydrogenated catalytically. Radio-gas 
chromatography and combined gas chromatography- 
mass spectrometry of the trimethylsilyl ethers of 
hydrogenated compounds A and B showed predomi- 
nant peaks with tR on 1.5% SE-30 of 1.04 and 1.38, 
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Fig. 3. Mass spectra of trimethylsilyl ethers of compound A (a) and compound B (b). 
respectively. Hydrogenated compounds A and B gave 
almost the same mass spectra (fig. 4 a and b). The 
spectra were practically identical with that of the 
trimethylsilyl ether of authetic 2a,3&dihydroxy-Sa- 
-pregnan-20-one (fig. 4 c). The molecular weight was 
478 and the base peak was at m/e 299 (M-(89 + 90, 
trimethylsiloxy group and trimethylsilanol)). 
Prominent peaks were seen at m/e 463 (M- 15), m/e 
338 (M-90) and m/e 143,142 and 129. Peaks at 
m/e 143, 142 and 129 are seen in 2,3-bis-trimethyl- 
siloxy steroids [7,8]. These results indicated that 
compounds A and B were the epimeric 2-hydroxy- 
pregnenolones. The relative retention times indicated 
that compound A was the 2&epimer and that com- 
pound B was the 2o-epimer. The fR of the 
trimethylsilyl ether of hydrogenated compound B 
was found to be 1.38 and the trimethylsilyl ether of 
2ar,3fldihydroxy-5at-pregnan-20-one has been repor- 
ted to have a fR of 1.34 under similar chromato- 
graphic conditions [7]. The question of the configu- 
ration at C-2 of compounds A and B was established 
by preparation of acetonides. Hydrogenated com- 
pounds A and B were treated with acetone and dry 
copper sulfate. Compound B remained unchanged 
after this treatment showing thatthe hydroxyl 
groups in compound B are oriented tram to each 
other. Compound A was transformed into a derivative 
which showed the mass spectrum expected of an 
acetonide of 2&3&dihydroxy-So-pregnan-20-one 
(fig. 4 d). The base peak was at m/e 359 (M-l 5) and 
a prominent peak was seen at m/e 299 (M-75). This 
fragmentation pattern is typical of acetonides of 
steroids with the vicinal hydroxyl groups in the steroid 
nucleus ([9], cf. also [5 and IO] ). 
4. Discussion 
In the previous study of the metabolism of preg- 
nenolone in the presence of microsomal fraction of 
rat liver homogenate fortified with NADPH [ 2],7o-, 
7P- and 16o-hydroxypregnenolone and 7-ketopreg- 
nenolone were identified as metabolites. The major 
metabolite could not be identified. The mass spec- 
trum of the trimethylsilyl ether of the unknown indi- 
cated the structure of a hydroxylated pregnenolone. 
On biological grounds it appeared very likely that the 
unknown had retained the A5 -3f3-hydroxy structure 
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Fig. 4. Mass spectra of trimethylsilyl ethers of hydrogenated compound A (a), hydrogenated compound B (b) and authenic 2&, 
3pdihydroxy-Scu-pregnan-20-one (c) and mass spectrum of acetonide of hydrogenated compound A (d). 
The 2ar,3p-diiydroxy-Sa-pregnan-2Gone was a generous gift of Dr. J.-A. Gustafsson. 
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of pregnenolone. The mass spectrum of the trimethyl- 
silyl ether of the unknown showed a very prominent 
base peak at M-90. Such a peak is found in mass 
spectra of As-3&hydroxysteroids having a hydroxyl 
group at C-7 of C-18 [6,9, 111. Since C-7 could be 
excluded it was suggested that the unknown could be 
18hydroxypregnenolone [2]. However, comparison 
of chromatographic and mass spectrometric data of 
an authentic sample of 5-pregnene-3&18,20fi-trio1 
with those of a sample of the unknown after reduc- 
tion with sodium borohydride showed that the com- 
pounds were not identical. At this stage of the inves- 
tigation the structure of 2-hydroxypregnenolone was 
considered less probable. The mass spectrum of the 
trimethylsilyl ether of the unknown did not show any 
prominent peaks at m/e 143,142 and 129. Such 
peaks are found in the spectra of steroids with a 2,3- 
-Es-trimethylsilyloxy structure [7,8]. However, the 
comparison spectra available were of compounds 
without a A5 double bond. The possibility that the 
presence of A5 double bond could influence the frag- 
mentation pattern had to be taken into account. A 
series of’stirdies to identify the unknown metabolite 
was therefore initiated. As described in the Results 
section the unknown has now been found to be a 
mixture of about 85% 2at-hydroxypregnenolone and 
about 15% 2&hydroxypregnenolone. These com- 
pounds have not been previously found in animal 
tissues. 2&-Hydroxylation of progesterone by rat 
liver microsomes has been reported [ 121 and 2~ 
-hydroxylated pregnane derivatives have been isola- 
ted from feces of rats [7] and have been shown to 
be formed from progesterone in the isolated perfused 
rat liver [8]. 
The results of the present and the previous inves- 
tigations [2] show the pronounced influence of the 
side chain on the pattern of hydroxylation of As -3& 
-hydroxysteroids by rat liver microsomes. The number 
of positions hydroxylated in dehydroepiandrosterone 
and pregnenolone contrasts sharply with that in 
cholesterol which in essence is hydroxylated only in 
the 7a-position. 
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